Keeping Current

Did you know that combining Bacillus Calmette-Guérin (BCG) with immunotherapy significantly improves outcomes in high-risk bladder cancer? Credit available for this activity expires: 2/24/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/immunotherapy-non-muscle-invasive-bladder-cancer-expert-2026a10005af?ecd=bdc_podcast_libsyn_mscpedu

Are you up to date on HER2 testing best practices? Join our expert panel and discover the critical updates that guide treatment selection. Credit available for this activity expires: 2/17/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/navigating-her2-spectrum-breast-cancer-evolving-diagnostic-2026a10004ea?ecd=bdc_podcast_libsyn_mscpedu

What do the latest data from the 2025 breast cancer Winter Conference tell us? Credit available for this activity expires: 02/02/2027 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/winter-conference-update-novel-and-emerging-treatment-2026a100030r?ecd=bdc_podcast_libsyn_mscpedu

Known as a "silent" disease because it has few or no symptoms, MASH increases cirrhosis, cancer, and death rates despite being both detectable and treatable. Credit available for this activity expires: 01/30/2027 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/case-based-journey-risk-results-2026a10002fy?ecd=bdc_podcast_libsyn_mscpedu

Are you up-to-date on the latest data in HER2-positive early breast cancer? Join our experts as they discuss the data and the clinical implications! Credit available for this activity expires: 01/29/2027 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/her2-positive-early-breast-cancer-what-latest-data-mean-your-2026a10002fg?ecd=bdc_podcast_libsyn_mscpedu

How can we optimize ART in people living with HIV while addressing comorbidities and minimizing toxicity? Credit available for this activity expires: 01/15/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/balancing-art-and-comorbidities-aging-people-living-hiv-2026a1000127?ecd=bdc_podcast_libsyn_mscpedu

Low-carbon inhalers: Are you finding the right balance for optimal patient care and planetary health? Credit available for this activity expires: 12/31/26 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/alarming-carbon-footprint-respiratory-disease-future-2025a1000y0k?ecd=bdc_podcast_libsyn_mscpedu

Are you asking about sleep, activity levels, and mood? Why you should be and what to do next. Credit available for this activity expires: 12/31/26 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/achieving-brain-health-epilepsy-what-can-clinicians-do-2025a1000y6t?ecd=bdc_podcast_libsyn_mscpedu

Discover the patients who need timely treatment for metabolic dysfunction–associated steatohepatitis (MASH). How will you find them? And then what will you do? Credit available for this activity expires: [12/30/26] Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/patient-case-challenge-how-would-you-manage-this-patient-2025a1000zqo?ecd=bdc_podcast_libsyn_mscped...

Alarming in immunoglobulin A nephropathy (IgAN): over 40% present late. Explore latest advancements in management of the most common cause of primary glomerulonephritis worldwide. Credit available for this activity expires: 12/23/26 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/navigating-challenges-igan-management-clinical-implications-2025a1000w9b?ecd=bdc_...

How well are you managing patients on EGFR inhibitor therapies in your clinical practice? Credit available for this activity expires: 12/18/26 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/person-centered-care-egfr-mutated-advanced-nsclc-optimizing-2025a1000xxa?ecd=bdc_podcast_libsyn_mscpedu

Learn from the experts about selecting the right BTK inhibitor therapy for patients with chronic lymphocytic leukaemia (CLL) in UK clinical practice. Credit available for this activity expires: 12/16/26 Earn Credit / Learning Objectives & Disclosures:  https://www.medscape.org/viewarticle/charting-course-cll-clinicians-compass-btk-inhibitor-therapy-2025a1000yei?ecd=bdc_podcast_libsyn_mscpedu

Did you know that, while well established in the metastatic setting, second-generation antibody-drug conjugates are now moving into the early setting? Credit available for this activity expires: 12/10/26 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/how-are-adcs-shaping-future-early-breast-cancer-care-latest-2025a1000yca?ecd=bdc_podcast_libsyn_mscpedu

Join the program for an in-depth discussion on low-grade glioma – from burden and diagnosis to therapies. Credit available for this activity expires: 12/10/26 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/pediatric-low-grade-glioma-braf-alterations-stories-science-2025a1000x3w?ecd=bdc_podcast_libsyn_mscpedu

Join this program for relevant updates across the advanced and metastatic breast cancer (mBC) spectrum as presented in October 2025. Credit available for this activity expires: 12/8/26 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/hot-topics-berlin-2025-what-experts-say-about-future-2025a1000x8r?ecd=bdc_podcast_libsyn_mscpedu

Where do oral selective estrogen receptor degraders (SERDs) fit in the overall landscape of first- and second-line advanced/metastatic breast cancer? Credit available for this activity expires: 12/04/26 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/how-are-oral-serds-changing-management-advanced-hr-positive-2025a1000xkg?ecd=bdc_podcast_libsyn_mscpedu

Preventing the first ASCVD is critically important. In this activity, we explore the evidence for early and intensive lipid lowering to significantly reduce patient's cardiovascular (CV) risk. Credit available for this activity expires: 12/05/26 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/staying-ahead-first-event-evaluating-evidence-early-ldl-c-2025a1000x...

Is your patient's proteinuria low enough? New KDIGO goals: target the immune cause and hit < 0.5 g/day to preserve kidney function.   Credit available for this activity expires: 12/2/2026 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1003055?ecd=bdc_podcast_libsyn_mscpedu

Are you up to date on emerging pharmacologic therapies transforming obesity and type 2 diabetes care? Credit available for this activity expires: 11/28/26 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/advances-pharmacologic-management-obesity-expert-digest-2025a1000v94

Do you know whom to treat and why? Learn about identifying and treating at-risk metabolic dysfunction-associated steatohepatitis (MASH). Credit available for this activity expires: 11/25/2026 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/breaking-silence-tackling-liver-fibrosis-mash-who-treat-2025a1000waj?ecd=bdc_podcast_libsyn_mscpedu

Are you looking beyond the lung to provide holistic care for your patients with multimorbid chronic obstructive pulmonary disease (COPD)? Credit available for this activity expires: 11/26/2025 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/coexisting-comorbidities-advancing-holistic-care-copd-2025a1000uiz?ecd=bdc_podcast_libsyn_mscpedu

Hear from our panel of obesity and diabetes experts about emerging obesity and type 2 diabetes therapies addressing cardiovascular, hepatic, and metabolic complications. Credit available for this activity expires: 11/25/2026 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1003022?ecd=bdc_podcast_libsyn_mscpedu

Does the year 2025 mark a true, tangible shift toward biomarker-driven precision medicine for metastatic hormone-sensitive prostate cancer (mHSPC)? Credit available for this activity expires: 11/18/26 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/latest-advances-mhspc-update-berlin-2025-2025a1000vlk?ecd=bdc_podcast_libsyn_mscpedu

Are you staying up to date on the latest practice-changing data revolutionizing the treatment for lung cancer? Credit available for this activity expires: 11/18/26 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/conference-insights-breaking-developments-alk-positive-nsclc-2025a1000vwn?ecd=bdc_podcast_libsyn_mscpedu

ADCs as first-line treatment?  ESR1 monitoring before progression? Local therapy for CNS disease? Experts tackle today's toughest decisions. Credit available for this activity expires: 11/14/2026 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/charting-course-metastatic-breast-cancer-care-optimizing-2025a1000v4s?ecd=bdc_podcast_libsyn_mscpedu